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1 Introduction
The chapter on NMR of lipids and membranes summarizes the literature
published between June 2010 and May 2011. The reviewed material has
been arranged in thematic sections which are focused on selected aspects of
lipidology, i.e. proteins/peptides – lipids interactions in the membranes,
covalently lipidated proteins, non-covalent lipoprotein complexes, lipids in
the membranes and glycolipids. A separate section devoted to metabonomic
studies is ﬁnally followed by a brief summary of the new NMR methods
designed to study peptides/proteins and lipids. We included in our review
only those papers which were accessible, peer-reviewed and printed. Finally,
we would like to admit that because of the space limits this review covers
only a selection of the published data.
2 Proteins/peptides – lipids interactions in the membranes
Studies on interactions of peptide/proteins with lipids are still a big
challenge in spite of the development of many new NMR techniques.
Various approaches employing simpliﬁed model lipid-protein interacting
systems and also natural partners interactions are summarized below.
a Eﬀect on lipid
Static NMR (2H and 31P) and rotational-echo double-resonance NMR
(13C REDOR) spectroscopy has been applied to probe the structure and
motion of model lipid membranes with bound human immunodiﬁcienct
virus (HIV) fusion peptide by Gabrys et al.1
Cheng et al.2 have used solid-state 31P NMR to determine the mode of
action of several aurein (antimicrobial peptide) mutants on mechanically
aligned POPC/POPG bilayers. Dudkina et al.3 have elucidated incorpora-
tion of water-soluble proteins into the PC liposomes using 31P NMR
spectra. Solid-state 31P and 2H NMR has been used by Sherman et al.4 to
investigate the eﬀect of antimicrobial peptide fallaxidin on the dynamics of
physpholipid multilamellar vesicles (mammalian-like DMPC and bacterial-
like DMPC/DMPG). The 31P and 2H NMR solid state experiments have
been used by Fernandez et al.5 to show the diﬀerences in the interactions
of the synthetic P5 antimicrobial peptide with the DPMC and anionic
(DPMC/DPMG) bilayers. Changes in membrane dynamics of DPME/
DPMG system upon addition of the antimicrobial maculatin 1.1 have been
characterized by Sani et al.6 with 31P MAS spectra.
The selectivity of antimicrobial peptides, PG-1 and IB484 against
Gram-positive and Gram-negative bacteria has been studied by Su et al.7
The LPS-rich and POPE/POPG membrane disorder caused by these
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arginine rich peptides have been observed using a range of solid-state
heteronuclear NMR experiments, including 31P MAS, 13C CP-MAS,
13C-13C DARR, DIP-SHIFT and 13C-31P REDOR.
Farver et al.8 have elucidated the eﬀect of pulmonary surfactant protein B
(N-terminal 25 amino acids) on lipid organization and polymorphism via
solid-state 31P and 2H NMR.
Haney et al.9 have reviewed techniques, including 2D NMR and 31P
NMR, to study antimicrobial peptides-lipids interactions that produce
positive or negative membrane curvature or cubic lipid phases.
b Eﬀect on peptide/protein
Ieronimo et al.10 have analyzed the eﬀect of antimicrobial peptide with a
selectively 19F labelled 4-CF3-phenylglycine from Xenopus laevis on the
protoplast membrane from bacterium Micrococcus luteus and from human
erythrocytes using 19F NMR.
Buer et al.11 have examined the feasibility of application of solution phase
19F NMR to study peptide-membrane interaction using the antimicrobial
peptide MSI-78 labelled with triﬂuoroethylglycine and model vesicles.
15N solid-state NMR spectroscopy has allowed Salnikov and Bechinger12
to ﬁnd that antimicrobial peptide, magainin 2 exhibits stable in-plane
alignments associated with the surface of DPMC/DPMG membranes
whereas PGLa adopts a number of diﬀerent topologies within the mem-
brane depending on lipid composition.
Bojko et al.13 have analyzed the eﬀect of fatty acid on interactions of
theophyline (diuretic, cardial stimulant and asthma medicament) with
human serum albumin by means of 1H NMR. The eﬀect of phosphorylation
on the structure of phospholamban (transmembrane protein that regulates
the cardiac cycle) incorporated into DOPC/DOPE mechanically oriented
membranes has been elucidated by Chu et al.14 by static 15N solid-state and
31P NMR. The same group, Chu et al.,15 has analyzed the eﬀect of N27A
mutation on phospholamban dynamics by 2H and 15N solid-state NMR.
Mineev et al.16 have analyzed the spatial structure of the heterodimeric
complex formed by transmembrane domains of ErbB1 and ErbB2 receptors
embedded into DMPC/DHPC bicelles by solution NMR (2D and 3D
1H15N and 1H13C HSQC, TOCSY, HNCA, HN(CO)CA, HNCACB and
CBCA(CO)NH, HCCH-TOCSY, 1H NOESY experiments).
Franzoni et al.17 have compared the structure and binding properties of
the main cytosolic retinol carriers – cellular retinol-binding proteins types I
and II (CRBP-I and II) using 2D TOCSY, NOESY, HSQC and 3D
NOESY-HSQC spectra.
Structural studies on the ABC transporter ArtMP from Geobacillus
stearothermophilus in native lipid environment have been performed by
Lange et al.18 by 13C MAS NMR. Using 1H spin diﬀusion solid-state NMR
experiments with 13C and 31P detection, Luo and Hong19 have determined
the water accessibility of the M2 transmembrane domain (of inﬂuenza A
virus) in virus-envelope-mimetic lipid membranes.
Shi et al.20 haveapplied ssMASNMR(3DNCOCX,NCACX,CONCAnd
4D CONCACX experiments) to characterize bacterial light-driven retinal-
binding proton pump – proteorhodopsin) in DMPC/DMPA liposomes.
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2DNMRhas been usedbyYamamoto et al.21 to elucidate the structures of a
series of designed a-helical peptides of various degrees of hydrophobicity and
stability, and to study their inﬂuence on the formation of two lipid domains in
an anionic liposome; by Zheng et al.22 to study the structure of core peptide,
CP, in aqueous solution and in DPC micelles; by Mishra et al.23 to determine
the structure of a 10-residue class G* peptide from apolipoprotein J in DPC
micelles; byGrace andCowsik24 to solve the conformation of non-mammalian
tachykinin physalaemin in DPCmicelles where lipid-induced a-helix has been
found fromPro4 to theC-terminus; byToke et al.25 to determine a helix-break-
helix conformation of maximin-4 in SDS micelles; by Saravanan and
Bhattacharjya26 to solve 3D structure of 22-residue peptide derived from
fowlicidin-1, VK22 in DPC micelles; by Walrant et al.27 to investigate the
secondary structure of three basic cell penetrating peptides (R9, RW9 and
RL9) in DPC or SDS micelles; by Plesniak et al.28 for initial structural char-
acterisation of theY. pestisAil membrane protein inDPMC,DHPC and LPG
micelles (the b-barrel has been found and additionally conﬁrmedwith SSNMR
measured in bilayers); by Metcalf et al.29 to explore dynamic behaviour of
the cross-linked aIIb and b3 cytoplasmic domains in DPC micelles.
2D heteronuclear solution NMR spectra of an 18-residue N-terminal
fragment of SP-B, unmodiﬁed and with oxidized tryptophan in the presence
of SDS or DPC have been measured by Sarker et al.30 The solution as well
as solid state 2H NMR POPC bilayers data have indicated that tryptophan
oxidation causes substantial disruption in helical structure of the peptide
and lipid interactions.
It has been shown by Lorieau et al.31 that charge-dipole interactions
between the N-terminal amino group (Gly1) and the second helix addi-
tionally stabilize helical hairpin structure of inﬂuenza hemagglutinin fusion
peptide in DPC micelles. From pH dependence of 15N and 13C chemical
shifts of Gly1 measured with the 3D HACAN CH2-TROSY experiment
pK value of 8.73 has been estimated. The structure of bombolitin II (BLT2),
the heptadecapeptide from the venom of bumblebee bound to DPPC
membrane has been studied by Toraya et al.32 13C NMR and 15N REDOR
spectra revealed that the structure of BLT2 is a straight rod of a-helix. 15N
solid-state NMR spectroscopy has allowed Heinzmann et al.33 to conﬁrm
that maximin-4 in DPMC/DPMG micelles preserves the kinked con-
formation found for this peptide in the solution.
T-state structural topology of phospholamban (PLN) pentamer in lipid
bilayers has been conﬁrmed by Verardi et al.34 using a hybrid solution and
solid-state NMR method. For this purpose 3D NMR solution spectra have
been measured for PLN with DPC micelles; 2D DARR MAS and 2D
1H,15N-PISEMA spectra have been measured for PLN with mechanically
aligned DOPC/DOPE bilayers.
2H NMR spectra have been used by Gu et al.35 to monitor the average
indole ring orientations and motions in doubly Phe-substituted gramicidin
A analogues, [Phe13,15]gA and [Phe9,11]gA in DPMC oriented samples:
diﬀerent backbone conformations have been found, the single stranded
b6.3-helical channel and double stranded, respectively.
Ordered conformation of distinctin on the surface of the membrane has
been documented by Verardi et al.36 using 15N, 31P, [1H-15N]-HSQC and
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SAMPI4 SSNMR; POPC/DOPE and POPC/DOPA bilayers have been
used for this purpose.
Grasnick et al.37 have studied the conformation, aggregation and
dynamics of ﬁve selective CF3-Phg and four selective D3-Ala labels of the
HIV fusion peptide embedded in phospholipid model membranes using 19F
and 2H solid state NMR.
1DHN residual couplings, relaxation rate constants R1 and R2 and
1H-15N
NOE’s have beenmeasured by Stewart et al.38 for the wild typeC1B domain of
protein kinase Ca, C1Ba and its Y123W mutant. The diﬀerences in the con-
formational behaviour between both proteins have been localized to the hinge
regions of diacylglycerol binding loops that may account for the W100 fold
increase in the mutant binding aﬃnity to lipid membranes containing DAG.
1H,13C and 1H,15N HSQC spectra have been used by Gustavsson et al.39
to investigate conformational changes upon chemical unfolding of
unphosphorylated monomeric phospholamban (AFA PLN) and its phos-
phorylated form (pS16-AFA-PLN) in the presence of DPC micelles. In
addition the [1H,15N] SEA-CLEANEX spectra have been measured for the
peptides and for other pseudophosphorylated S16D-AFA-PLN, and S16E-
AFA-PLN mutants. The resulting exchange data, averaged [1H,15N]–NOE
and normalized chemical shifts have been shown to correlate linearly with
inhibition of each peptide.
Lu et al.40 have found that the peptide corresponding to the single
transmembrane segment of APP exists partially in nonhelical conforma-
tions in POPC bilayers; 13C NMR have been used in these studies.
The presence of the multiple resonances per site of membrane bound
transmembrane domain of M2 in 15N and 13C SSNMR spectra measured
under diﬀerent conditions has been attributed by Hu et al.41 to diﬀerent
conformational states of the peptide.
Using 13C solid-state NMR and 13C1-Val1 gramicidin in DPMC bilayers
Jones et al.42 have demonstrated that the valine residue exist in two slowly
exchanging conformations with lifetimes of several seconds.
Molecular segments engaged in fast, large amplitude ﬂuctuations
(so-called ‘J-residues’) of proteorhodopsin in DMPC/DMPA bilayer have
been identiﬁed using high-resolution solid-state NMR by Yang et al.43 The
inﬂuence of lipid bilayer properties, water and temperature on the protein
dynamics has been studied using a broad range of 1D and 2D J- and dipolar
coupling-based experiments, i.e. CC-INEPT-TOBSY, CC-DARR, 13C-CP,
13C-INEPT, HC-INEPT-HETCOR and WISE spectra.
McDonald et al.44 have studied orientation and dynamics of three helical
polypeptides comprising GpATM dimerization motifs in POPC bilayers; 2H
NMR spectra have been measured for this purpose.
Vostrikov et al.45 have studied importance of outer tryptophans in
Ac-GWW(LA)nWWA-NH2 peptides on the peptide tilt within lipid bilayer
membranes. In these studies the peptides of the sequence Ac-GXALW-
(LA)6LWLAXA-NH2 (where X=W, K, R or G) and DLPC, DMPC and
DOPC bilayers have been used. With the aid of 2H NMR it was found that
W5 and W19 determine the direction of the tilt.
It has been shown by Kalli et al.46 that mutations in the four basic resi-
dues in the talin F2 domain reduce the aﬃnity of the talin head (F2-F3,
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Tal2198-408) domain for the membrane and change its relative orientation
in the bilayer. These ﬁndings have been supported by monitoring shift
perturbations in 1H-15N HSQC NMR spectra of mutated versus wild type
domains in the presence of liposomes.
The eﬀect of binding of palmitic acid on the structure and dynamics of the
Sterol Carrier Protein of mosquitoe Aedes aegipty has been analyzed by
Singarapu et al.47 by a series of two- and three-dimentional heteronuclear
NMR spectra, e.g. 1H-15N HSQC, HNCO, HNCACB, CBCA(CO)NH,
15N-resolved 1H-1H NOESY, 13C,15N-ﬁltered/15N-edited 1H-1H NOESY,
13C,15N-ﬁltered/13C-edited 1H-1H NOESY, 13C-ﬁltered 1H-1H TOCSY.
The mechanism of binding interaction between lysozyme and liposomes
composed of phosphatidylcholine and cholesterol has been investigated
with the aid of 31P NMR by Witoonsaridsilp et al.48
Fatty acid binding protein has been studied by He et al.49 who have
exploited 15N-edited HSQC signal formed during stepwise ligand (oleate)
titration to yield the stoichiometric characterization of the complex.
P"oskon´ et al.50 have analyzed the involvement of bacterial acyl carrier
protein (ACP) in fatty acid biosynthesis by acquiring the 1H-15N sensitivity
enhanced HSQC, HNCACB, CBCA(CO)NH, HCCH-TOCSY NMR
spectra of intermediates covalently bound to ACP.
Lowden et al.51 have used 1H, 13C and 2D TOCSY, NOESY, HMQC and
HMBC spectra to prove the presence of cis-palmitoleate (16:1) bound to the
pocket in the N-terminal domain of ToxT (Vibrio cholerae transctription
factor).
Pettersson-Kastberg et al.52 have elucidated how the lack of native three-
dimentional structure in the a-lactalbumin protein positively contributes to
the selective in vivo tumoricidal activity of the complex of this protein with
oleic acid; 1D 1H and diﬀusion NMR spectra were obtained.
The structure of p7 protein of hepatitis C virus (forming ion channel)
incorporated into the 14-O-PC/6-O-PC bicelles has been studied by Cook
and Opella53 by solid state NMR (1D 15N, 2D SAMMY spectra). Cook
et al.54 have also established an eﬃcient protocol for p7 overproduction in
E. coli; and Cook and Opella55 have suggested a model of the architecture of
p7 in magnetically aligned DHPC micelles using solution NMR (1H,15N
HSQC, HNCA, 1H,15N NOE experiments) and a solid-state NMR.
It has been shown by Fan et al.56 that it is possible to obtain solid state
NMR spectra of a eukaryotic 7TM helical protein in lipids (DMPC/
DMPA) with the resolution leading to the assignment of majority of
backbone and side-chains resonances.
Several 3D SSNMR experiments have been employed by Shi et al.57 to
solve the structure of a seven-helical transmembrane photosensor, sensory
rhodopsin from Anabaena sp. PCC 7120 in lipid environment. A number of
notable structural diﬀerences have been found in comparison to X–ray data.
Two dimensional 1H,15N-TROSY spectra of hVDAC1 in LDAO have
been measured by Villinger et al.58 The protein dynamics was analyzed in
detail and compared with its X-ray structure.
Concepts and novel developments in oriented solid-state NMR used for
investigation of membrane associated polypeptides have been reviewed by
Bechinger et al.59 Hong and Su60 have reviewed solid-state NMR techniques
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used to study the structure and dynamics of cationic memebrane peptide
and proteins.
Investigation of transmembrane alignment of host defence peptides with
the aid of 15N solid-state NMR spectra has been reviewed by Bechinger.61
Chicken ileal bile-acid-binding protein 3D structure has been solved by
Guariento et al.62 with the aid of 3D heteronuclear NMR spectroscopy and
its interactions with glycocholic and glycochenodeoxycholic acids have been
monitored with 1H,15N HSQC spectra.
c Simultaneous elucidation of the eﬀects on lipid and protein
Butterwick and MacKinnon63 have used 2D (TROSY HSQC) and 3D
NMR (TROSY, NOESY) to determine the structure and phospholipid
interface of the voltage-sensor domain from the voltage-dependent Kþ
channel (from bacteria Aeropyrum pernix); association of bilayer-forming
phospholipids was analyzed (fast HSQC spectra) using paramagnetically
labelled compounds (16-doxyl PSPC).
Walther et al.64 have used solid-state 31P and 15N NMR to resolve the
membrane alignment of the pore-forming TatAd (subunit of translocase
responsible for protein export in Bacillus subtilis) and subsequent mem-
brane lipid orientation in DMPC/DMPG/6-O-PC bicelles; high-resolution
2D separated local ﬁeld method – polarization inversion spin exchange at
the magic angle (SAMMY) experiment was used.
Solid-state 2D 1H-13C and 3D 1H-13C-13C MAS NMR has been applied
by Kijac et al.65 to examine lipid-protein interface in POPC nanodiscs
containing truncated membrane scaﬀolding protein (MSP1) and to deter-
mine the gel-to-liquid crystal lipid phase transition.
Schmick and Weliky66 have determined the fraction of parallel structure
in membrane (14-O-PC/14-O-PG/cholesterol) -associated N-terminal
region of gp41 by solid-state 13C MAS NMR (REDOR experiment).
The eﬀect of anesthetics (halothane or isoﬂurane) on the structure
and dynamics of transmembrane domain T2 of the neuronal nicotinic
acetylcholine receptor incorporated into DMPC/DHPC bicelles has been
investigated by Cui et al.67 using solid-state 2H and 2D 15N-1H PISEMA
NMR experiments; the eﬀects of anesthetics on the lipid bilayers have been
followed too.
Pedo` et al.68 have performed NMR investigation (1H,15N TROSY,
1H,15N HSQC, 2D 15N-edited NOESY) on the role of membranes (DMPG
liposomes) in the binding of bile acids to bile acid binding protein.
Stark et al.69 have suggested the biological function of YndB of Bacillus
subtilis by NMR titration experiment (2D 1H,15N HSQC) following the
in silico screen of lipid ligands. The structure and alignment of the cationic
antimicrobial peptide arenicin incorporated into POPC or POPE/POPG
membranes have been evaluated by Salnikov et al.70 using 31P and 15N
solid-state NMR (1D and 2D PISEMA experiment). Mao et al.71 have
elaborated a E.coli-based Single-Protein-Production system for solid-state
13C MAS NMR analysis of uniformly 13C, 15N enriched ATP synthase
subunit c in natural bacterial membrane. Park et al.72 have characterized
the local and global dynamics of the chemokine receptor CXCR1 using a
combination of solution NMR (1H,15N HSQC, TROSY, 3D 15N-edited
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NOESY-HSQC, HNCA, HNCOCA experiments in isotopic bicelles) and
solid-state NMR (1D stationary and MAS 15N spectra using magnetically
oriented and unoriented bicelles).
Interaction of de novo synthesised K4 peptide with phospholidpids has
been analyzed by Legrand et al.73 with the 31P and PSGE NMR
experiments.
Thennarasu et al.74 have studied the interaction of the synthetic peptide
(KFAKKFA)3-NH2, MSI-367 with the POPC bilayers using
2H and 31P
NMR and found that the peptide is localized at the membrane surface.
The eﬀects of peptide hydrophobicity on its incorporation in phos-
pholipid membrane have been investigated by Ora¨dd et al.75 using three
variants of the antimicrobial peptide CNY21, POPE or POPC membranes
and 2H and PSGE NMR spectroscopy.
Sugawara et al.76 have investigated interaction of several catestatin-
derived peptides with POPC/POPS micelles. It appears that these peptides
adopt partially a-helical structure whereas the 31P and 15N solid-state NMR
data indicate that this short helix causes disordering at the level of the
membrane phospholipid head groups.
31P NMR spectra measured by Cheng et al.77 for POPC/POPG and CL/
POPG bilayers interacting with aurein 2.2 and its variants have revealed the
importance of membrane composition for functioning of the aurein
peptides.
13C[31P]-REDOR SSNMR spectra have been measured by Hughes
et al.78 for PLM38-72, the phospholemman cytoplasmic domain with kidney
membrane revealing peptide-lipid interactions. Kobashigawa et al.79 have
proposed phosphoinositide-incorporated lipid-protein nanodiscs as a tool for
studying protein-lipid interactions with the aid of proton and 31P NMR.
He et al.80 have used 3D heteronuclear NMR spectra to solve the
structure of the FAPP1 pleckstrin homology domain and 1H,15N HSQC
spectra to monitor on the molecular level interaction of the protein with
phosphatidyloinositol 4-phosphate. The same type of experiments has been
used by Ankem et al.81 to demonstrate the C2 domain of Tollip binding to
phosphoinositides in the presence of Car2þ and by Zhang et al.82 to monitor
binding of the 15N-labelled Grp1 PH to diﬀerent 5-stabilized phosphati-
dyloinositol 3,4,5-triposphate analogues. 1H,15N HSQC spectra have served
Fernandes et al.83 to study interactions of the matrix protein of HIV-1 with
phosphatidylinositol phosphates.
The S227-245 segment of glycosyltransferase atDGD2 has been evaluated
by Szpryngiel et al.84 as the possible site involved in lipid interactions. The
induced a-helical structure of the segment in DPC micelles has been found
using 2D NMR techniques and the interactions of the peptide with zwit-
terionic or anionic bicells have been checked by measurement of diﬀusion
coeﬃcients in PFG NMR experiments.
Hydrodynamic radii of wt, nit-Y39F and Y125/133/136D a-synuclein
have been measured by Sevcsik et al.85 using PFG NMR in the studies
of long-range interactions in this protein and their importance for the
membrane binding ability.
Binding of palmitic acid to CD4 has been well documented with 1D STD
NMR experiments by Lee et al.86
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Raschle et al.87 have reviewed recent developments on nonmicellar
systems with a particular focus on their application to solution NMR
studies of membrane proteins. NMR studies demonstrating diﬀerences
between two viroporins: p7 of HCV and Vpu of HIV1 have been sum-
marized by Cook et al.88 The emergence of solution NMR spectroscopy as a
powerful tool for the structural characterization of membrane-associated
protein domains involved in transmembrane signaling has been presented
by Call and Chou.89
3 Lipidated proteins and peptides
Covalent lipidation of proteins is a biological phenomenon with various
chemical and physiological implications. It is substantial for protein
hydrophobicity and is thought to be crucial for the association of lipidated
protein with the cellular membranes as well as for protein-protein interac-
tion, protein folding and stability. Several recent papers have been focused
on these topics.
Liu et al.90 have reported a high-resolution NMR structure of full-length
myristoylated yeast Arf1 protein in a complex with DMPC/DHPC bicelles.
Theisgen et al.91 using 2H solid-state and 1H-15N HSQC solution spectra
have shown that both myristolyated and non-myristolyated GCAP-2 pro-
teins have very similar binding energies to phospholipid bilayers.
The structure of antifungal cyclic heptapeptides lipidated (with 16:0 to
18:0 alkyl side chain) of Bacillus amyloliquefaciens has been estimated by
Romano et al.92 by 1D 1H and 13C and 2D NMR (COSY, HOHAHA,
HSQC, HMBC).
Spanedda et al.93 have used NMR to characterize four new water soluble
lipidopeptidic immunoadjuvants.
2D 1H NMR spectra of LPT1b, a post-translationally modiﬁed form of
barley lipid transfer protein with lipid like adduct on the side chain of Asp7,
have been measured by Mills et al.94 before and after heating to 100 1C.
It has been shown that the protein refolds back after heating. The hydro-
dynamic radii of the studied species have been obtained from the PFG
NMR measurements.
2H NMR has been used by Penk et al.95 to show that N-terminal lipid
modiﬁcations of transmembrane a-helices are membrane-inserted. The
study was performed using LV16ac peptides in POPC and DLPC
membranes.
Theisgen et al. have reviewed the studies on the applications of solid-state
NMR to analyze the N-terminus of the myristoylated proteins.
4 Lipoproteins (non-covalent complexes)
Lipoprotein complexes are involved in intercellular lipid transport which is
a prerequisite of lipid (cholesterol, triacylglycerols and others) homeostasis
in human. For this reason many studies are focused on elucidation of
lipoprotein structure and metabolism.
1H NMR spectra of human plasma samples have been analyzed for
determination of lipoprotein subclasses (size and concentration) by Muth
et al.,96 by Tejero et al.,97 by Al-Shahrouri et al.98 in connection with type 2
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diabetes diagnostics, by Arsenault et al.,99 by Kostara et al.100 as a pre-
diction of coronary heart disease, by Chung et al.101 as diagnostic measure
of atherosclerosis in patients with rheumatoid arthritis. 1H NMR spectra of
human plasma samples have also been acquired by Schmelzer et al.102 to
analyze the eﬀect of ubiquinol supplementation on the level of LDL.
Rat serum metabolic proﬁle has been investigated by Zhao et al.103 using
1H NMR-based metabolomic in order to follow the eﬀect of quercetin,
ﬂavonoid component of the diet, on lipoprotein proﬁle.
New structural details of the nascent High-Density Lipoproteins have
been described by Gogonea et al.104 using 31P NMR in combination with
various biophysical platforms together with molecular dynamics.
Bancells et al.105 have used 1H NMR to monitor LDL fusion and to
evaluate the degradation of phospholipids.
2D HR NMR (1H-13C HSQC) has been employed to characterize the
surface-exposed lysine residues of the apolipoprotein (apo)B-100 protein in
LDL subfractions by Blanco et al.106
Go´mez et al.107 have employed 1H NMR to check an eventual fusion of
LDL particles in their oxidation with Cu and Fe ions.
Systemic dyslipidemia and lipoprotein modiﬁcation caused by acrolein
consumption have been shown by Conklin et al.108 in acrolein-fed mice. The
examinations of lipoproteins were carried out with the aid of NMR.
DOSY has been applied by Coles et al.109 for accurate measurement of
particle size of lipopetides.
5 Lipids and membranes
Cellular and organellar membranes are dynamic structures that trigger
many aspects of cell function. Studies on various aspects of lipid interac-
tions and membrane dynamics are summarized below.
a Lipid structure and dynamics
The structure of 7-hydroperoxycholesterol (synthetic standard and food
component) has been identiﬁed by Nogueira et al.110 using 13C NMR.
Gao et al.111 have used 1H and 13C NMR for identiﬁcation of the
structure of six titanocenyls functionalized with steroids – potential antic-
ancer drugs. The structure of metabolites of 3-substituted ergosterol formed
by microbial degradation (anologs of vitamine D) has been analyzed by
Dovbnya et al.112 using 1H NMR. Yamazaki et al.113 have used 1H and
13C NMR (HSQC, NOESY) to analyze the structure of pentacecilides,
inhibitors of lipid droplet formation in macrophages, produced by
Penicillium cecidicola. 1H and 13C NMR have been used for analysis of
polyhydroxylated sterols of sponge Callyspongia ﬁbrosa with an anti-
malarial activity by Rao et al.114 while analogous derivatives of starﬁsh
Asterina pectinifera with antiviral and cytotoxic activities have been studied
by Peng et al.115 (in the latter case 1H-1H COSY and HMBC spectra were
also collected). Vı´lchez et al.116 have elucidated the structure of trans-2-
decenoic acid, a novel interkingdom-signaling molecule inhibiting the yeast-
to-hyphal transition of Candida albicans using 1H and 13C NMR. The
structute of new cytotoxic steroidal alkaloids from Kibatalia laurifolia has
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been elucidated by Phi et al.117 using 1D 1H and 13C and 2D COSY, HSQC
and NOESY experiments. The structure of tuberatolides, meroterpenoid
antagonists of the Farnesoid X Receptor isolated from Botryllus tuberatus
has been established by Choi et al.118 using 1D 13C and 2D HMBC and
DEPT experiments. Jarret et al.119 have used time domain NMR for
eavaluation of the seed oil content of 1100 accessions of okra. The structure
of sixteen plakortolides (containing bicyclic poroxy-lactone ring) isolated
from sponge Plakinastrella clathrata has been established by Yong et al.120
by 1D 1H and 2D NMR (HMBC, HSQC, NOESY experiments). Structures
of two new eicosanoids with a unique isovalerianic acid ester moiety from
the gorgonian Dichotella gemmacea have been established by Wang et al.121
using 1D 1H and 13C and 2D COSY, HMQC, HMBC and DEPT experi-
ments. Eighteen new diterpenes have been structurally characterized by
Hayes et al.122 using 1D 1H and 13C and 2D COSY, ROESY and HMBC
experiments. Antibacterial sphingolipids and steroids of black coral Anti-
pathes dichotoma have been isolated and characterized by Al-Lihaibi
et al.123 using 1D 1H and 13C and 2D COSY, HMQC, HMBC and
DEPT experiments. The structure of novel prenyl bibenzyls of liverwort
Marsupidium epiphytum has been established by Toyota et al.124 using 1D
1H and 13C and 2D COSY, HMBC and NOESY experiments.
31P NMR has been used in combination with diﬀerent analytical tech-
niques by Lobasso et al.125 to analyze the lipids present in total extracts of
olfactory neuroepithelium.
Heteronuclear NMR spectra have been used to solve the structure
of three bioactive acylphloroglucinols isolated from the aerial parts of
Hypericum densiﬂorucm Pursch by Henry et al.;126 of six meroterpenoids
of chromene class isolated from Sargassum siliquastrum by Lee and Seo.127
The solution structure of 40-phosphopantetheine-GmACP3 from
Geobacter metallireducens has been solved by Ramelot et al.128 using
restraints obtained from NMR spectra.
The presence of two major phosphatidylserine headgroup conformations
in calcium-induced clusters of this lipid in POPS/POPC bilayer has been
demonstrated by Boettcher et al.129 using 2D SSNMR 13C-13C, 15N-13C and
31P-13C spectra.
Leftin and Brown130 have reported a database with experimental NMR
parameters for membrane phospholipids which may be useful for validation
of molecular simulations.
The structures of chemically randomized (sodium methoxide treated) oils
from seal blubber and menhaden with modiﬁed positional distribution of
fatty acids have been investigated by Wang et al.131 using quantitative 13C
NMR. Lessig and Fuchs132 have examined the hypochlorous acid-induced
plasmalogen degradation in a model mixture of polyunsaturated plasma-
logens using HR 31P NMR. The structure of the alkaline degradant of
Ezetimibe, a selective inhibitor of intestinal cholesterol absorption has been
established using 1H and 13C NMR by Gajjar and Shah.133 Side chain
cholesteryl polymers (mesogen-like) have been sythesized and evaluated
structurally with 1H NMR by Wang et al.134 Magnusson et al.135 have
applied 1H NMR to evaluate the regiopurity of the synthesized 72 ether
lipids of 1-O-alkyl-2,3-diacyl-sn-glycerol type. Vaique et al.136 have
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synthesized a set of triacylglycerols with n-3 polyunsaturated fatty acids;
their purity has been checked by 1H and 13C NMR.
Xu et al.137 have isolated and characterized over a dozen oxysterols
formed in the free radical oxidation of 7-DHC using 1D and 2D NMR.
Griesser et al.138 using 1H NMR have identiﬁed two cyclic hemiketal
eicosanoids as the major products of the nonenzymatic rearrangement of
the diendoperoxide.
Blanco et al.139 have synthesised 6-methylnitroarachidonate and char-
acterized the structure of this nitro-fatty acid using heteronuclear 2D NMR.
Quantitative 31P NMR spin trapping has been used by Zoia et al.140 to
study the mechanism of enzymatic oxidation of linoleoic acid by soybean
lipoxygenases-1.
Indentiﬁcation of soybean lipoxygenase-1 products by Zheng and
Brash141 with the aid of 1D 1H and 2D COSY NMR has permitted its
biochemical characterization as a bifunctional enzyme.
The structure of paleic acid, an antibiotic obtained from a fermentation
broth of Paenibacillus sp., has been elucidated by Kurata et al.142 by means
of 1D 1H and 13C and 2D NMR (DEPT, HMQC, COSY, TOCSY and
HMBC spectra).
Osipova et al.143 have characterized substrate speciﬁcity of plant lipoxy-
genases by identiﬁcation the structure of their oxylipin products using 1H
NMR and 2D COSY.
Time-resolved 31P MAS direct polarization and cross polarization tech-
niques have been used by Ullrich et al.144 to simultaneously follow ATP
hydrolysis and the DGK (diacylglycerol kinaze) catalyzed phosphorylation
of DOG (1,2-dioctanoylglycerol) in DOPC bilayers.
The structure of fatty acid derivatives as components of glandular tri-
chome exudates of Ibicella lutea and Proboscidea louisiana have been elu-
cidated by Asai et al.145 by means of 1H and 13C NMR.
The polar lipids of Clostridium tetani, the causative agent of tetanus, have
been examined using 1D 1H, 13C, 31P and 2D COSY, HMQC, HMBC
NMR by Johnston et al.146
Metabolic relationship between the synthesis of polyhydroxyalkanoic
acid and rhamnolipid (two biotechnologically important compounds) in
Pseudomonas aeruginosa has been analyzed by Choi et al.147 via quantitative
13C NMR following the metabolic labelling with [1-13C]octanoic acid.
Tsukada et al.148 have studied the biosynthesis of jasmonic acid in a plant
pathogenic fungus Lasiodiploidia theobromae using metabolic labelling with
[2H6]linolenic acid followed by
2H NMR.
Maatooq et al.149 have used proton and carbon homo- and hetero-
correlated NMR spectra to identify seven metabolites of biotransformation
of 18b-glycyrrhetinic acid.
Gylfason et al.150 have analyzed the lipid content of extracts of lipid rafts
from Atlantic cod intestinal enterocytes by 31P NMR.
The structures of N-acylated bacteriohopanehexol-mannosamides from
the thermophilic bacterium Alicyclobacillus acidoterrestris have been solved
by Rˇezanka et al.151 with the aid of 1H and 13C NMR. Monolysocardiolipin
has been characterised with 1H NMR by Kim and Hoppel152 as a pre-
ferential product of cardiolipin hydrolysis in methanol. The sizes of
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DPhPC/DPhPE vesicles have been determined by Andersson et al.153 using
NMR diﬀusion experiments.
Equivalence of dehydration and osmotic pressures in lipid membrane
deformation has been demonstrated byMallikarjunaiah et al.154 using solid-
state 2H NMR and DPMC bilayers.
Frankel155 has reviewed analytical methods used for the authentication of
extra virgin olive oil. This includes 1H, 13C, 31P NMR used in studies of
EVOO adulteration.
b Lipid – lipid interactions
Mihailescu et al.156 have shown that addition of cholesterol to poly-
unsaturated lipid bilayers (18:0-22:6n3-PC) increases the order parameters
of DHA and stearyl acid chain; 2H NMR and 13C-MAS NMR have been
used in this study.
Scheidt et al.157 have used a combination of solid-state NMR methods
(2H, 1H MAS, 2D 1H MAS) to investigate the membrane orientation and
transversal distribution of 17b-estradiol in model POPC membranes. The
phase behaviour of mixtures of palmitic acid and various sterols has been
characterized by 2H NMR at diﬀerent pH by Cui et al.158
The eﬀect of E,Z isomers of monoenoic fatty acids on the DMPC
membrane ﬂuidity (the supramolecular lamellar structure during gel – ﬂuid
transition) has been analyzed by Filippelli et al.159 using 2H NMR.
Teixeira et al.160 have checked the solubility of oleanolic acid in melted
stearic acid by means of 1H NMR.
The eﬀect of cholesterol on the magnetic induced orientation of
sphingomyelin/cholesterol multilamellar vesicles has been examined using
static solid-state 31P MAS NMR by Castello and Alam.161 The eﬀect of
cholesteryl sulfate on the stability of DMPC/DHPC bicelles has been tested
by Shapiro et al.162 by NMR measurement of 2H quadrupole splittings in
D2O, while the utility of the cholesteryl sulfate containing bicelles has been
tested using 15N HSQC-IPAP NMR following the addition of 15N-
ubiquitin. The mode of tocotrienol entrapment/association with the lipid
nanoparticles (four high melting point lipids were tested) has been evaluated
by Ali et al.163 by 1H NMR.
Guillermo et al.164 have used 13C HR CPMAS and PFGSTE experiments
for morphological characterisation of two lipid-based formulations of lip
gloses, D014 and D019.
13C CPMAS NMR has been used by Shih et al.165 to study the-
conformations of two steroid hormones, dehydroepiandrosterone and
spironolactone in the DPMC/DHPC mixture.
Unilamellar liposomes made up of DOTAP, DOPE and a novel
amphiphile lauroyl uridine have been characterized with 1H NMR by
Cuomo et al.166
c Lipid – drug interactions
2D 1H MAS NMR (NOESY) analysis has been applied by Hoﬀmann
et al.167 to visualize the direct insertion of polyprenylated acylphloro-
glucinolhyperforin, the modulator of phospholipase A2 activity, into
POPC liposomes. Ma et al.168 have studied the structure of inclusion
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complexes of cyclodextrins with cortisone acetate (steroidal drug) by means
of 2D 1H NMR(ROESY). The eﬀect of sodium bicarbonate (pharmaceutical
formulation excipient) on the interaction of ﬂuvastatin (anticholesterolemic
drug) with membrane phospholipids (DMPC/DMPS mixture mimicking the
gut cell membranes) has been investigated by Larocque et al.169 using 1H
NMR. Jensen et al.170 have studied interaction of cisplatin (anticancer drug)
with POPS liposomes using a broad range of solid-state NMR techniques. i.e.
13C MAS, 31P, 15N and 15N{31P}REDOR experiments. Smith et al.171 have
used SSNMR to gain insight into the structure of the DMPC-dendrimer
(poly(amidoamine) polymer for targeted drug delivery) complex; static 31P
and 14N and MAS R-PDLF, NOESY, RFDR and 1H NMR spectroscopies
have been used.
The eﬀect of quipazine and LY-165,163, two serotonin receptor 1a ago-
nists on the phase behaviour of DPPC/cholesterol bilayers has been studied
by Batchelor et al.172 using 1H MAS NMR spectra.
The encapsulation of doxorubicin or vinorelbine into PEG/PE micelles
has been proved by Wang et al.173 using 2D 1H NOESY spectra.
Su et al.174 have investigated the interaction of PMX30016 with POPC,
POPG, POPS, DPMC, DPMG and 6-O-PC. Orientation, depth of insertion
and dynamics of this antimicrobial arylamide in bilayers have been deter-
mined with 19F and 31P solid state NMR.
Sharma et al.175 have reviewed the investigations of drug binding to three
conductance domains of viral porins (M2 proteins from inﬂuenza A and B,
and viral protein ‘u’ from HIV-1) and their mutants, performed with
PISEMA spectra in bilayers.
6 Glycolipids
The structure of various natural glycolipids has been analyzed using NMR.
Lin et al.176 have identiﬁed two sterol glycosides inhibiting the cancer cell
growth in the red alga Peyssonnelia. Ono et al.177 have elucidated the
structure (1D 1H and 13C NMR spectra) of oligoglycosides of hydroxy fatty
acid methyl esters isolated from seeds of Pharbitis nil.
Pas´ciak et al.178 have established the structure of glycolipids from
Arthrobacter scleromae and A.globiformis utilizing 1D 1H and 13C and 2D
NMR (COSY, TOCSY, ROESY, HSQC-DEPT and HMBC experiments).
2D NMR spectroscopy has been used by Silipo et al.179 to elucidate the
structure of the carbohydrate backbone of the core-lipid A region of the
lipooligosaccharide from Halmonas sp.; by Morando et al.180 to reveal
structural features of the Nod factor synthetic analogues; by Layre et al.181
to identify in the wild-type strain of Mycobacterium tuberculosis new
di-acylated sulfoglycolipids esteriﬁed by simple fatty acids and mono-
acylated sulfoglycolipids bearing hydroxyphthioceranoic acid; by Jang
et al.182 to elucidate the structures of lipoteichoic acids isolated from
Lactobacillus plantarum.
Konishi et al.183 with the aid of proton and carbon NMR have deter-
mined the structure of biosurfactant produced by Pseudozyma hubeiensis
SY62. The major product has been identiﬁed as 4-O-[40-O-acetyl-20,30-di-O-
alka(e)noil-b–D-mannopyranosyl]-D-erythritol.
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A speciﬁc interaction of new synthetic amphiphilic glycolipids (antisepsis
agents) with CD14 have been proved by Piazza et al.184 with the aid of STD
NMR spectroscopy.
The inﬂuence of the concentration of deep rough mutant ReLPS from
E. coli strain WBB06 on the size of raft domain in membranes composed of
a phospholipid (DEPE), cholesterol and sphingomyelin (egg-SM) has been
studied by Nomura et al.185 using 13C and 31P solid state NMR.
7 Metabonomic studies
The high-throughput studies on cellular metabolom are continuously
being developed. Metabolomic approaches open new perspectives for the
development of new diagnostic tools and speed up the progress in therapy
of various metabolic disorders. The number of NMR applications for
metabonomic in vitro and in vivo studies has signiﬁcantly increased during
recent year. Selected papers are summarized below.
1H NMR spectra of urine samples have been utilized by Kim et al.186
for metabolomic proﬁling of cholesterol and low-density lipoproteins. A
similiar approach has been used by Lu et al.187 to follow the metabonomic
pattern after oral administration of polychlorinated bifenyls and 2,3,7,8-
tetrachlorodibenzo-p-dioxin (endicrine disruptors). 1H NMR spectra of rat
urine, serum and 1H MAS NMR spectra of liver have been used by Bollard
et al.188 to identify biomarkers of liver regeneration folowing partial
hepatectomy.
1H NMR (1D, 2D COSY, TOCSY, HSQC) based metabolic proﬁling of
mouse feces has been carried out by Martin et al.189 in diﬀerent microbiome
mouse models (including gnotobiotic mouse inoculated with a model of
human baby microbiota). The eﬀects of probiotics on colonic inﬂammation
has been assessed by Hong et al.190 by metaboling proﬁling of the fecal
extracts of mice using 1H NMR with NOESYPR pulse sequence and 2D
TOCSY, HMBC, HSQC experiments.
1H NMR supported with diﬀerent types of statistics has been used in
analysis of metabolic proﬁles of the diabetic nephropathy streptozotocin
induced in rats by Zhao et al.;191 of lipidome and metabolome of rat
cardiomyocytes after EPA or DHA supplementation by Righi et al.;192 of
metabolic proﬁling of serum of accelerated aging mice (ERCC1d/-) by
Nevedomskaya et al.;193 of lipid proﬁles in urine and plasma of inbred rat
strains by Pontoizeau et al.;194 of metabolites including lipids in rabbit
aqueous humour after the glucocorticosteroids administration by Song
et al.;195 of alternations in the levels of LDL/VLDL in patients with renal
cell carcinoma by Zira et al.;196 of levels of lipid moieties in patients with
minimal hepatic encephalopathy by Jime´nez et al.;197 of the levels of lipid
metabolites in serum in kidney transplant recipients with cyclosporine A- or
tacrolimus-based immunosuppresion by Kim et al.;198 of mucosal colonic
biopsies, colonocytes, lymphocytes and urine from patients with ulcerative
colitis by Bjerrum et al.;199 of LDLp and HDLp in patients with coronary
artery endothelial dysfunction by Ford et al.;200 of lipid proﬁles in
extracts of gallbladder tissues in chronic cholecystitis and cancer by
Jayalakshmi et al.201
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1H NMR metabolic phenotyping has been developed to identify bio-
markers of rheumatoid arthritis (cholesterol and other lipids) by Lauridsen
et al.,202 to identify chronic lymphocytic leukaemia disease-state biomarkers
by MacIntyre et al.,203 to reveal progression axes for glucose intolerance
and insulin resistance statuses by Zhang et al.204
1H HRMAS NMR (1D NOESYPR and 2D TOCSY) has been applied to
unravel the eﬀects of three natural marine products with antineoplastic
activity in intact human MCF7 breast cancer cells by Bayet-Robert et al.205
The same group, Bayet-Robert et al.206 has designed a method for quan-
titative 2D 1H HRMAS NMR metabolite proﬁling of intact human cancer
cells and response to chemotherapy.
Fernando et al.207 have elucidated the eﬀect of ethanol-induced fatty liver
by 1H and 31P NMR analysis of lipids from rat plasma and liver.
A robust method for the simultaneous quantiﬁcation of major biliary
lipids has been deviced by Ijare et al.208 using 1H NMR spectroscopy. 1H
and 31P NMR analysis (1D and 2D COSY and TOCSY) of lipid compo-
nents in the tissue, serum and cerebrospinal ﬂuid has been performed by
Srivastava et al.209 to develop a diagnostic tool for evaluation of brain
tumours.
Triba et al.210 have used 1H HR-MAS NMR for elucidation of anti-
proliferative drugs (doxorubicin and bisphosphonates) on metabolic (lipid)
proﬁles of whole B16 melanoma cells.
Lutz and Cozzone have performed multiparametric studies aimed at
optimization of 31P NMR measurements of brain phospholipids in crude
tissue extracts focused on the eﬀects on chemical shift211 and on the line
width and spectral resolution.212
In vivo single-voxel MRS and ex vivo 1H HR NMR have been used by
Mosconi et al.213 to study the composition of adipose tissues in Zucker
obese and lean rats.
To examine a potential link between the choline metabolism and phos-
phoinositide 3-kinase/Akt signalling Romanska et al.214 have compared the
metabolic proﬁles of murine pluripotent embryonic stem cells and the
embryonal carcinoma cell using 1H NMR spectra of cell extracts.
1H NMR-based (1D PRESAT and spin-echo spectra) metabonomic
analysis of human serum has been developed by Mao et al.215 to follow the
progresssion of critically ill patients from Systemic Inﬂammatory Response
Syndrome to Multiple Organ Dysfunction Syndrom.
Quantitative 1H NMRmetabolomics has been applied by Xu et al.216 to
follow the speciﬁc mitochondrial toxicities in vitro in myotube cells.
1D, COSY and TOCSY 1H NMR and 1D 31P NMR spectra of serum
lipids in Duchenne muscular dystrophy patients have been measured and
quantiﬁed by Srivastava et al.217 1H and 13P NMR metabolomics have
been applied by van Patot et al.218 to quantify lipid metabolites in human
placental tissue biopsies. The study has shown the presence of labour
oxidative stress in placentas from pregnancies at sea level but not in those
at 3100 m. Hepatic lipid composition in patients with chronic hepatitis C
has been analysed in vitro and in vivo by Cobbold et al.219 using 1H MRS.
The results show signiﬁcant dependence of the lipids proﬁle on the disease
severity.
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Levels of lipoproteins and lipids in serum of more than 4000 healthy adults
have beenmeasured byWu¨rtz et al.220with 1HNMRandused in the analysis of
metabolic phenotypes associated with subclinical atherosclerosis. The results of
metabonomic studies carriedout by Inouye et al.221with the aidof 1HNMRfor
a large population-based cohort combined with transcriptomic and genomic
analysis have revealed that the lipid-leukocyte module has a prominent role in
over 80 serummetabolites including lipoprotein subclasses and lipids. Chasman
et al.222 have performed a genome-wide association studies (GWAS) for 22
lipoprotein measures derived from NMR-based and conventional assays in a
population ofmore than seventeen thousandwomen. 43 genetic loci involved in
lipoprotein metabolism have been found in these studies.
Signals from intra- and extra-myocellular lipids have been assigned
in 1D 1H and L-COSY NMR spectra collected for human soleus muscle
in vivo at 7T by Ramadan et al.223 It has been shown that at this ﬁeld strength
all signals from multiple lipid compartments are shifted by 0.20 to 0.26 ppm.
Metabolic ﬁngerprinting of medicinal plant extracts (leaf and root of
Withania somnifera) has been elucidated by Chatterjee et al.224 with the aid
of 1H NMR including 1H-13C HSQC experiment. Lipid composition of
intact algal cells which are used for biodiesel production has been analyzed
by Beal et al.225 by means of a liquid state 13C and liquid state 31P NMR.
Bunescu et al.226 have performed in vivo 1H HRMAS NMR metabolic
proﬁling of the cladoceran Daphnia magna of diﬀerent physiological status.
Szeto et al.227 have observed inherent biological variation of 1H NMR
metabolic proﬁles of yeast and nematode model systems. Szeto et al.228 have
also examined exometabolome of the yeast Saccharomyces cerevisiaemutants
defective in succinate dehydrogenase (model of mitochondrial dysfunction)
using 1H NMR.
Metabolites obtained from Caenorhabditis elegans using twelve combi-
nations of diﬀerent techniques of tissue extraction and disruption have been
compared by Geier et al.229 1H NMR has been used for detection of lipids.
Micro-Raman spectroscopy for quantitative determination of the unsa-
turation index in mammal fat tissues has been calibrated against 1H HR
NMR by Giarola et al.230 The usage of Raman spectroscopy does not
require chemical extraction of the lipid component.
8 New NMR methods
a For peptides/proteins
Chu et al.231 have developed a new tool to study membrane proteins which
permits to determine the membrane immersion depth of a spin-labelled
probe using paramagnetic relaxation enhancement (PRE) in solid-state 31P
NMR; a DOXYL spin labelled PSPC was used.
Gopinath et al.232 have presented new sensitivity enhanced schemes for
heteronuclear correlation spectroscopy (HETCOR) in solid-state NMR of
oriented systems.
Lu et al.233 have established a general assignment method for oriented
sample solid-state NMR of proteins based on correlation of resonances
through heteronuclear dipolar couplings in samples aligned parallel and
perpendicular to the magnetic ﬁeld.
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Jayanthi et al.234 have presented a new sequence named 24-SEMA for
obtaining reliable dipolar couplings in membrane proteins oriented in lipid
bilayers and liquid crystals. Under oﬀ-resonance conditions intensities of sig-
nals from the new sequence are several folds higher than that from PISEMA.
Well resolved spectra of proton detected solid-state NMR H/N correla-
tions of perdeuterated and partially proton-back-substituted membrane
proteins have been demonstrated by Linser at al.235 The method has been
validated using the outer membrane protein G in perdeuterated E. coli lipid
bilayer and bacteriorhodopsin.
Using virtual NMR data Esteban-Martı´n et al.236 have demonstrated that
dynamic data analysis of peptides in membrane depends critically on the
choice of isotope labelling scheme. For example: 15N labels accommodated
within the peptide backbone will yield nearly correct peptide helix tilt angle
whereas CD3 or CF3 groups attached to the Ca–Cb bond will yield this angle
severely underestimated.
Several new approaches that combine cell-free expression and diﬀerent
labelling strategies for preparing a membrane protein sample for solid-state
NMR measurements have been overviewed by Abdine et al.237 These
approaches will hopefully lead to a protein structure determination in the
solid state using NMR technique.
b For lipids
Kupce and Freeman238 have proposed a fast-PANACEA experiment
(combination of three standard NMR pulse sequences INADEQUATE,
HSQC and HMBC into a single entity) for fast analysis of cholesterol.
A novel self-oriented system made of a fatty acid hexagonal phase has
been established by Douliez239 using 2H solid-state NMR. Kashima and
Okabayashi240 have developed a system with an on-line immobilized enzyme
reactor integrated into liquid chromatography-NMR for identiﬁcation of
enzymatic reaction products with application of 1H and 2D 1H-1H NMR.
It has been shown by Yamamoto et al.241 that the inclusion of Cu2þ ions
in bicelles results in a 10-fold reduction of T1 and in 6.2 fold decrease in
MAS experimental time.
Kielar et al.242 have designed a bis-substituted DOTA derivative GdIII
complex and shown that, incorporated into liposomes, it causes signiﬁcant
enhancement of relaxivity.
Diﬀusion-weighted 1H MRS spectroscopy has been implemented by
Zietkowski et al.243 to monitor mobile lipids in cervical tissue biopsies.
The lipid composition of human muscle has been measured by Webb
et al.244 in a 7T system with a coil producing a longitudinal travelling wave.
It was possible to obtain localized proton spectra with the coil placed 30 cm
away from the region of interest.
9 Miscellaneous
Gao et al.245 have used 1H NMR to show formation of hydrogen bonding
between molecules of a new gelator (cholesterol based and sugar
containing).
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Lee et al.246 have applied in vivo 1H NMR (STEM spectra) for detection
of early responses to radiation that precede tumour volume changes.
Quintero et al.247 have elucidated the compartmentalization of the bio-
synthesis of triacylglycerols in C6 rat glioma cells by acquiring the 2D
HMQC NMR spectra of the total lipid extracts of cells upon labelling with
[1-13C]glucose.
The interactions of poxvirus particles with small unilamellar vesicles
composed of DPPG, the main component of pulmonary surfactant, have
been studied by Debouzy et al.248 using 1H NMR.
Pages et al.249 have applied fast-recording diﬀusion-diﬀraction (pulsed
ﬁeld-gradient spin-echo, PGSE) 1H NMR to follow the change of ery-
throcyte shape, from an echinocytic stage to normal discocytic shapes due
to the modulation of Mg2þ; simultaneusly 31P NMR was used to report on
metabolism during the shape reversion, while the membrane phospholipid
distribution of the cells was investigated with 1H spin-echo NMR.
The loss of N-oleoylethanolamine during tissues extractions has been
proved by Skonberg et al.250 who have identiﬁed the product of its reaction
with chloroform with the help of 1H NMR.
Freikman et al.251 have studied the inﬂuence of oxidative stress on
membrane lipid composition using 1H NMR.
Oxygen distribution across the MLMPC bilayer has been monitored by
Al-Abdul-Wahid et al.252 using 13C paramagnetic chemical shift perturba-
tions for 18 diﬀerent sites of this lipid.
Using 129Xe NMR Meldrum et al.253 have characterized the interactions
of the xenon-cryptophane-A cage molecular sensor with lipid vesicles under
diﬀerent conditions.
The rate of phosphocreatine recovery after exercise have been measured
by van den Broek et al.254 with 31P MRS in vivo and found to be a sensitive
measure of skeletal muscle mitochondrial function.
Water and fat thermal MRI has been demonstrated by Soher et al.255
using water-fat fanthoms. This approach may be applied for accurate
tumour and normal tissue temperature measurements in hypothermic
treatment.
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